Skye Bioscience Inc (SKYE)
6.30
+0.80
(+14.55%)
USD |
NASDAQ |
Jul 08, 10:23
Skye Bioscience Research and Development Expense (TTM): 6.581M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.581M |
| December 31, 2023 | 5.820M |
| September 30, 2023 | 5.765M |
| June 30, 2023 | 6.292M |
| March 31, 2023 | 5.931M |
| December 31, 2022 | 6.012M |
| September 30, 2022 | 5.588M |
| June 30, 2022 | 4.134M |
| March 31, 2022 | 3.587M |
| December 31, 2021 | 2.931M |
| September 30, 2021 | 2.188M |
| June 30, 2021 | 2.207M |
| March 31, 2021 | 1.754M |
| December 31, 2020 | 1.944M |
| September 30, 2020 | 2.290M |
| June 30, 2020 | 2.457M |
| March 31, 2020 | 2.717M |
| December 31, 2019 | 2.238M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.760M |
| June 30, 2019 | 1.314M |
| March 31, 2019 | 0.626M |
| December 31, 2018 | 0.33M |
| September 30, 2018 | 0.1623M |
| June 30, 2018 | 0.1836M |
| March 31, 2018 | 0.2442M |
| December 31, 2017 | 0.3113M |
| September 30, 2017 | 0.5045M |
| June 30, 2017 | 0.4965M |
| March 31, 2017 | 0.8958M |
| December 31, 2016 | 0.939M |
| September 30, 2016 | 1.019M |
| June 30, 2016 | 1.091M |
| March 31, 2016 | 0.6743M |
| December 31, 2015 | 0.5761M |
| September 30, 2015 | 0.2654M |
| June 30, 2015 | 0.3081M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.754M
Minimum
Mar 2021
6.581M
Maximum
Mar 2024
3.800M
Average
2.931M
Median
Dec 2021
Research and Development Expense (TTM) Benchmarks
| Cutera Inc | 19.94M |
| Zymeworks Inc | 129.75M |
| OrthoPediatrics Corp | 10.92M |
| RAPT Therapeutics Inc | 100.21M |
| NovaBay Pharmaceuticals Inc | 0.061M |